Related Experiment Videos
[Long-term results with the CARE classification for assessing operability before thoracic surgery].
1Medizinische Universitätsklinik, Abt. Pneumonologie, Homburg/Saar.
Pneumologie (Stuttgart, Germany)
|February 1, 1990
Summary
The CARE scheme classifies individual risk to guide peri-operative therapy and reduce long-term morbidity. Tumor recurrence and progression exclusively determine patient prognosis, regardless of surgical intervention.
Area of Science:
- Oncology
- Surgical Risk Assessment
- Patient Prognosis
Context:
- Assessing individual patient risk is crucial for effective peri-operative and post-operative care.
- Tumor recurrence and progression are the primary determinants of outcomes in cancer patients.
Purpose:
- To evaluate the utility of the CARE scheme for risk classification.
- To determine the impact of risk stratification on therapeutic strategies and patient outcomes.
- To elucidate the exclusive role of tumor recurrence and progression in prognosis.
Summary:
- The CARE scheme provides a framework for classifying and quantifying individual patient risk.
- This classification facilitates the selection of appropriate function-supporting therapies during the peri-operative and post-operative periods.
- The study highlights that tumor recurrence and progression are the sole factors influencing the prognosis of both operated and non-operated cancer patients.
Impact:
- Improved patient stratification for tailored peri-operative and post-operative interventions.
- Potential reduction in long-term morbidity through optimized supportive care.
- Enhanced understanding of prognostic factors in oncology, emphasizing tumor dynamics over surgical status.